Value Factory Ventures invests in Foamlab, a spin-off from Delft University of Technology developing a new generation of bio-based foam materials. In this €3 million funding round, Value Factory joins ICOS Capital, DOEN Ventures, Capricorn Industrial Biotech Fund and the TTT Green Tech Fund (SHIFT Invest).
The investment enables Foamlab to build a pilot plant, scale production, and accelerate the commercial rollout of its technology.
A sustainable alternative to fossil-based foams
Foamlab develops foam materials based on bacterial cellulose, a natural and renewable material produced through fermentation. These materials offer a circular alternative to traditional fossil-based foams, which are widely used in applications such as packaging, textiles, furniture, and construction.
The technology allows for a wide range of material properties, from soft, textile-like structures to rigid, load-bearing applications. This makes Foamlab’s solution broadly applicable while maintaining a minimal environmental footprint.
Accelerating the bio-based materials transition
With this investment, Value Factory supports the transition towards a circular and bio-based economy. Foamlab’s technology enables the replacement of fossil-based foams with scalable, sustainable alternatives based on bacterial nanocellulose. Applications range from construction insulation to high-end packaging and fashion.
By addressing how materials are produced and used, Foamlab contributes to a fundamental shift in the materials landscape — offering a solution that is both industrially scalable and circular.
The growing demand for sustainable materials highlights the potential of Foamlab’s technology. With this new funding, the company is well positioned to expand production capacity and further scale its first commercial applications.
